910404-93-2 Usage
Derivative of phenylethylamine
2-(3-(pyriMidin-2-yl)phenyl)ethanaMine is derived from phenylethylamine, which is a type of organic compound that contains a benzene ring attached to an aminoethyl group.
Contains a pyrimidine ring
Pyrimidine is a heterocyclic aromatic ring structure that is similar in shape to a benzene ring, but contains nitrogen atoms instead of carbon atoms. The presence of a pyrimidine ring in 2-(3-(pyriMidin-2-yl)phenyl)ethanaMine indicates that it has a specific chemical structure and properties that are different from other derivatives of phenylethylamine.
Potential applications in medicinal chemistry
2-(3-(pyriMidin-2-yl)phenyl)ethanaMine has potential uses in the development of pharmaceuticals, which could include the treatment of various diseases and medical conditions.
Uses in academic research
2-(3-(pyriMidin-2-yl)phenyl)ethanaMine may also be used as a building block in the synthesis of more complex organic molecules, which could be useful in academic research to study and understand the properties and behavior of new compounds.
Need for further study and evaluation
The specific properties and potential uses of 2-(3-(pyriMidin-2-yl)phenyl)ethanaMine would need to be further studied and evaluated through experiments and testing to determine its full range of applications and potential benefits.
Check Digit Verification of cas no
The CAS Registry Mumber 910404-93-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,0,4,0 and 4 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 910404-93:
(8*9)+(7*1)+(6*0)+(5*4)+(4*0)+(3*4)+(2*9)+(1*3)=132
132 % 10 = 2
So 910404-93-2 is a valid CAS Registry Number.
910404-93-2Relevant academic research and scientific papers
NOVEL INHIBITOR COMPOUNDS OF PHOSPHODIESTERASE TYPE 10A
-
, (2013/02/28)
The present invention relates to novel carboxamide compounds, pharmaceutical compositions containing them, and their use in therapy. The compounds possess valuable therapeutic properties and are particularly suitable for treating or controlling medical disorders selected from neurological disorders and psychiatric disorders, for ameliorating the symptoms associated with such disorders and for reducing the risk of such disorders
